Narrowband UVB phototherapy in vitiligo: Evaluation of results in 53 patients

S. Percivalle, R. Piccinno, M. Caccialanza, S. Forti

Research output: Contribution to journalArticle

Abstract

Aim. Narrowband UVB (NBUVB)phototherapy has been used for vitiligo for years, but today there are no standardized protocols of treatment and follow-up data. A long-term study on 53 patients with localized or diffuse vitiligo is presented with the aim at improving the data availability in the literature. Methods. Phototherapy was administered two times a week on non-consecutive days; the treatment was continued for one year. The mean total dose administered was 201.28 J/cm2. The response to phototherapy was expressed as percentage of repigmentation: a repigmentation greater than 75% was considered excellent, a repigmentation between 74% and 50% good, a repigmentation between 49% and 25% moderate, a repigmentation less than 24% mild. In case of absence of repigmentation, the patient was judged as non-responder Results. Three point eight percent of patients showed excellent response, 32.05% good response, 32.05% moderate response, 283% mild response, while the remaining 3.8% was not responsive. According to statistical analysis best responses, were observed in non-acral areas (P

Original languageEnglish
Pages (from-to)9-14
Number of pages6
JournalGiornale Italiano di Dermatologia e Venereologia
Volume143
Issue number1
Publication statusPublished - 2008

Fingerprint

Vitiligo
Phototherapy
Clinical Protocols
Therapeutics

Keywords

  • Phototherapy
  • Ultraviolet rays
  • Vitiligo

ASJC Scopus subject areas

  • Dermatology

Cite this

Narrowband UVB phototherapy in vitiligo : Evaluation of results in 53 patients. / Percivalle, S.; Piccinno, R.; Caccialanza, M.; Forti, S.

In: Giornale Italiano di Dermatologia e Venereologia, Vol. 143, No. 1, 2008, p. 9-14.

Research output: Contribution to journalArticle

@article{2f4780bafa034efc9a3f73605aa41e4d,
title = "Narrowband UVB phototherapy in vitiligo: Evaluation of results in 53 patients",
abstract = "Aim. Narrowband UVB (NBUVB)phototherapy has been used for vitiligo for years, but today there are no standardized protocols of treatment and follow-up data. A long-term study on 53 patients with localized or diffuse vitiligo is presented with the aim at improving the data availability in the literature. Methods. Phototherapy was administered two times a week on non-consecutive days; the treatment was continued for one year. The mean total dose administered was 201.28 J/cm2. The response to phototherapy was expressed as percentage of repigmentation: a repigmentation greater than 75{\%} was considered excellent, a repigmentation between 74{\%} and 50{\%} good, a repigmentation between 49{\%} and 25{\%} moderate, a repigmentation less than 24{\%} mild. In case of absence of repigmentation, the patient was judged as non-responder Results. Three point eight percent of patients showed excellent response, 32.05{\%} good response, 32.05{\%} moderate response, 283{\%} mild response, while the remaining 3.8{\%} was not responsive. According to statistical analysis best responses, were observed in non-acral areas (P",
keywords = "Phototherapy, Ultraviolet rays, Vitiligo",
author = "S. Percivalle and R. Piccinno and M. Caccialanza and S. Forti",
year = "2008",
language = "English",
volume = "143",
pages = "9--14",
journal = "Minerva dermatologica",
issn = "0392-0488",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "1",

}

TY - JOUR

T1 - Narrowband UVB phototherapy in vitiligo

T2 - Evaluation of results in 53 patients

AU - Percivalle, S.

AU - Piccinno, R.

AU - Caccialanza, M.

AU - Forti, S.

PY - 2008

Y1 - 2008

N2 - Aim. Narrowband UVB (NBUVB)phototherapy has been used for vitiligo for years, but today there are no standardized protocols of treatment and follow-up data. A long-term study on 53 patients with localized or diffuse vitiligo is presented with the aim at improving the data availability in the literature. Methods. Phototherapy was administered two times a week on non-consecutive days; the treatment was continued for one year. The mean total dose administered was 201.28 J/cm2. The response to phototherapy was expressed as percentage of repigmentation: a repigmentation greater than 75% was considered excellent, a repigmentation between 74% and 50% good, a repigmentation between 49% and 25% moderate, a repigmentation less than 24% mild. In case of absence of repigmentation, the patient was judged as non-responder Results. Three point eight percent of patients showed excellent response, 32.05% good response, 32.05% moderate response, 283% mild response, while the remaining 3.8% was not responsive. According to statistical analysis best responses, were observed in non-acral areas (P

AB - Aim. Narrowband UVB (NBUVB)phototherapy has been used for vitiligo for years, but today there are no standardized protocols of treatment and follow-up data. A long-term study on 53 patients with localized or diffuse vitiligo is presented with the aim at improving the data availability in the literature. Methods. Phototherapy was administered two times a week on non-consecutive days; the treatment was continued for one year. The mean total dose administered was 201.28 J/cm2. The response to phototherapy was expressed as percentage of repigmentation: a repigmentation greater than 75% was considered excellent, a repigmentation between 74% and 50% good, a repigmentation between 49% and 25% moderate, a repigmentation less than 24% mild. In case of absence of repigmentation, the patient was judged as non-responder Results. Three point eight percent of patients showed excellent response, 32.05% good response, 32.05% moderate response, 283% mild response, while the remaining 3.8% was not responsive. According to statistical analysis best responses, were observed in non-acral areas (P

KW - Phototherapy

KW - Ultraviolet rays

KW - Vitiligo

UR - http://www.scopus.com/inward/record.url?scp=42249114492&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42249114492&partnerID=8YFLogxK

M3 - Article

C2 - 18833047

AN - SCOPUS:42249114492

VL - 143

SP - 9

EP - 14

JO - Minerva dermatologica

JF - Minerva dermatologica

SN - 0392-0488

IS - 1

ER -